Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4294223
Max Phase: Preclinical
Molecular Formula: C43H70N12O16S
Molecular Weight: 1043.17
Molecule Type: Small molecule
Associated Items:
ID: ALA4294223
Max Phase: Preclinical
Molecular Formula: C43H70N12O16S
Molecular Weight: 1043.17
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)NC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O)C(=O)N[C@H](C(=O)N[C@@H](C)C(N)=O)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C43H70N12O16S/c1-17(2)28(51-37(65)24-9-8-13-54(24)41(69)31(21(7)57)53-39(67)29(18(3)4)50-35(63)22(44)16-72)38(66)48-23(36(64)52-30(20(6)56)40(68)47-19(5)34(45)62)10-11-26(58)46-15-25-32(60)33(61)42(71-25)55-14-12-27(59)49-43(55)70/h12,14,17-25,28-33,42,56-57,60-61,72H,8-11,13,15-16,44H2,1-7H3,(H2,45,62)(H,46,58)(H,47,68)(H,48,66)(H,50,63)(H,51,65)(H,52,64)(H,53,67)(H,49,59,70)/t19-,20+,21+,22-,23-,24-,25+,28-,29-,30-,31-,32+,33+,42+/m0/s1
Standard InChI Key: SKYWPXKMJASVAN-YFRVPUSZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1043.17 | Molecular Weight (Monoisotopic): 1042.4753 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zhang H, Tomašič T, Shi J, Weiss M, Ruijtenbeek R, Anderluh M, Pieters RJ.. (2018) Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids., 9 (5): [PMID:30108977] [10.1039/C8MD00115D] |
Source(1):